Loading clinical trials...

HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI) | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT02013310

HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)

This is a Phase 2 randomized, multicenter, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of HT-0712 in improving memory and cognitive performance in subjects with Age...

Lead sponsor: Dart NeuroScience, LLC•16 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment119

Start dateDec 2013

Last updatedDec 30, 2015

Condition

Age-Associated Memory Impairment (AAMI)

Locations shown

Sun City, Arizona

Long Beach, California

Santa Monica, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 30, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions